Daejung Chemicals & Metals

대정화금 · 120240

Materials Chemicals · KOSDAQ

Small-cap

Market cap US$71.1M (₩98.1B)

Overview

Daejung Chemicals & Metals makes chemical reagents, precise-grade substances used to detect or measure other chemicals in laboratory and industrial testing, as well as electronic-grade solvents and active pharmaceutical ingredients, the raw chemical inputs used in finished medicines.

Its products reach chemical manufacturers and pharmaceutical companies across South Korea and through export. Listed on KOSDAQ, Korea's tech and small-cap exchange, the company operates two distinct business lines: a reagents division serving research, biotech, and environmental industries, and a pharmaceutical raw-materials division supplying excipient ingredients to drug makers.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$78.3M
▲ +17.1% YoY
Operating profit · FY2025
US$8.1M
▲ +31.9% YoY
Net income · FY2025
US$9.8M
▲ +40.0% YoY

Revenue

  • FY2023US$67.6M
  • FY2024US$66.9M
  • FY2025US$78.3M

Operating profit

  • FY2023US$8M
  • FY2024US$6.1M
  • FY2025US$8.1M

Net income

  • FY2023US$9.4M
  • FY2024US$7M
  • FY2025US$9.8M

Key ratios (FY2025)

ROE
7.4%
Debt/Eq
14.7%
Op. margin
10.3%
Net margin
12.5%
Rev. YoY
▲ +17.1%

Why it matters

Named customers in the filing include LG Chem, Hyosung, Chong Kun Dang, and Boryung Pharmaceutical, spanning both the chemical and pharmaceutical sectors.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.